Diabetes, cardiovascular risk and nephropathy

Allison J. Hahr, Mark E. Molitch*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Diabetic patients with chronic kidney disease are at high risk for cardiovascular disease (CVD). All aspects of risk reduction should be rigorously applied to such patients. Statins should be used with reduction of low-density lipoprotein cholesterol levels, and blood pressure management is important. Glycemic control remains important for reduction in the development and progression of retinopathy, neuropathy, and even nephropathy itself. Reduction of other risk factors, such as smoking cessation and weight reduction, should also be implemented. Multiple risk factor reduction can have a large effect on reduction of CVD outcomes.

Original languageEnglish (US)
Pages (from-to)467-475
Number of pages9
JournalCardiology Clinics
Issue number3
StatePublished - Aug 2010


  • Cardiovascular risk
  • Diabetes mellitus
  • Nephropathy
  • Risk reduction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Diabetes, cardiovascular risk and nephropathy'. Together they form a unique fingerprint.

Cite this